|
1
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Bang YJ, Van Cutsem E, Feyereislova A,
Chung HC, Shen L, Sawaki A, Lordick F, Ohtsu A, Omuro Y, Satoh T,
et al: Trastuzumab in combination with chemotherapy versus
chemotherapy alone for treatment of HER2-positive advanced gastric
or gastro-oesophageal junction cancer (ToGA): A phase 3,
open-label, randomised controlled trial. Lancet. 376:687–697. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Fang C, Wang W, Deng JY, Sun Z, Seeruttun
SR, Wang ZN, Xu HM, Liang H and Zhou ZW: Proposal and validation of
a modified staging system to improve the prognosis predictive
performance of the 8th AJCC/UICC pTNM staging system for gastric
adenocarcinoma: A multicenter study with external validation.
Cancer Commun (Lond). 38:672018. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Yoon JY, Sigel K, Martin J, Jordan R,
Beasley MB, Smith C, Kaufman A, Wisnivesky J and Kim MK: Evaluation
of the prognostic significance of TNM staging guidelines in lung
carcinoid tumors. J Thorac Oncol. 14:184–192. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Shao Y, Geng Y, Gu W, Ning Z, Huang J, Pei
H and Jiang J: Assessment of lymph node ratio to replace the pn
categories system of classification of the tnm system in esophageal
squamous cell carcinoma. J Thorac Oncol. 11:1774–1784. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Khorana AA and Fine RL: Pancreatic cancer
and thromboembolic disease. Lancet Oncol. 5:655–663. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Miller GJ, Bauer KA, Howarth DJ, Cooper
JA, Humphries SE and Rosenberg RD: Increased incidence of neoplasia
of the digestive tract in men with persistent activation of the
coagulant pathway. J Thromb Haemost. 2:2107–2114. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Balkwill F and Mantovani A: Inflammation
and cancer: Back to Virchow? Lancet. 357:539–545. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Mantovani A, Allavena P, Sica A and
Balkwill F: Cancer-related inflammation. Nature. 454:436–444. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Arends J, Bodoky G, Bozzetti F, Fearon K,
Muscaritoli M, Selga G, van Bokhorst-de van der Schueren MA, von
Meyenfeldt M; DGEM (German Society for Nutritional Medicine), ;
Zürcher G, et al: ESPEN guidelines on enteral nutrition:
Non-surgical oncology. Clin Nutr. 25:245–259. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Bozzetti F, Arends J, Lundholm K,
Micklewright A, Zurcher G and Muscaritoli M; ESPEN: ESPEN
Guidelines on parenteral nutrition: Non-surgical oncology. Clin
Nutr. 28:445–454. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Xu Q, Yan Y, Gu S, Mao K, Zhang J, Huang
P, Zhou Z, Chen Z, Zheng S, Liang J, et al: A novel
inflammation-based prognostic score: The fibrinogen/albumin ratio
predicts prognoses of patients after curative resection for
hepatocellular carcinoma. J Immunol Res. 2018:49254982018.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wang YY, Liu ZZ, Xu D, Liu M, Wang K and
Xing BC: Fibrinogen-albumin ratio index (fari): A more promising
inflammation-based prognostic marker for patients undergoing
hepatectomy for colorectal liver metastases. Ann Surg Oncol.
26:3682–3692. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Xu WY, Zhang HH, Xiong JP, Yan XB, Bai Y,
Lin JZ, Long JY, Zheng YC, Zhao HT and Sang XT: Prognostic
significance of the fibrinogen-to-albumin ratio in gallbladder
cancer patients. World J Gastroenterol. 24:3281–3292. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Li SQ, Jiang YH, Lin J, Zhang J, Sun F,
Gao QF, Zhang L, Chen QG, Wang XZ and Ying HQ:
Albumin-to-fibrinogen ratio as a promising biomarker to predict
clinical outcome of non-small cell lung cancer individuals. Cancer
Med. 7:1221–1231. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zou YX, Qiao J, Zhu HY, Lu RN, Xia Y, Cao
L, Wu W, Jin H, Liu WJ, Liang JH, et al: Albumin-to-fibrinogen
ratio as an independent prognostic parameter in untreated chronic
lymphocytic leukemia: A retrospective study of 191 cases. Cancer
Res Treat. 51:664–671. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
You X, Zhou Q, Song J, Gan L, Chen J and
Shen H: Preoperative albumin-to-fibrinogen ratio predicts severe
postoperative complications in elderly gastric cancer subjects
after radical laparoscopic gastrectomy. BMC Cancer. 19:9312019.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Yu W, Ye Z, Fang X, Jiang X and Jiang Y:
Preoperative albumin-to-fibrinogen ratio predicts chemotherapy
resistance and prognosis in patients with advanced epithelial
ovarian cancer. J Ovarian Res. 12:882019. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ying J, Zhou D, Gu T, Huang J and Liu H:
Pretreatment albumin/fibrinogen ratio as a promising predictor for
the survival of advanced non small-cell lung cancer patients
undergoing first-line platinum-based chemotherapy. BMC Cancer.
19:2882019. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhang L, Zhang J, Wang Y, Dong Q, Piao H,
Wang Q, Zhou Y and Ding Y: Potential prognostic factors for
predicting the chemotherapeutic outcomes and prognosis of patients
with metastatic colorectal cancer. J Clin Lab Anal. 33:e229582019.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Eisenhauer EA, Therasse P, Bogaerts J,
Schwartz LH, Sargent D, Ford R, Dancey J, Arbuck S, Gwyther S,
Mooney M, et al: New response evaluation criteria in solid tumours:
Revised RECIST guideline (version 1.1). Eur J Cancer. 45:228–247.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Singh P, Toom S and Huang Y: Anti-claudin
18.2 antibody as new targeted therapy for advanced gastric cancer.
J Hematol Onco. 10:1052017. View Article : Google Scholar
|
|
23
|
Thomassen I, van Gestel YR, van Ramshorst
B, Luyer MD, Bosscha K, Nienhuijs SW, Lemmens VE and de Hingh IH:
Peritoneal carcinomatosis of gastric origin: A population-based
study on incidence, survival and risk factors. Int J Cancer.
134:622–628. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Shimada H, Noie T, Ohashi M, Oba K and
Takahashi Y: Clinical significance of serum tumor markers for
gastric cancer: A systematic review of literature by the task force
of the japanese gastric cancer association. Gastric Cancer.
17:26–33. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Sun DW, An L and Lv GY: Albumin-fibrinogen
ratio and fibrinogen-prealbumin ratio as promising prognostic
markers for cancers: An updated meta-analysis. World J Surg Oncol.
18:92020. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Wu M, Pan Y, Jia Z, Wang Y, Yang N, Mu J,
Zhou T, Guo Y, Jiang J and Cao X: Preoperative plasma fibrinogen
and serum albumin score is an independent prognostic factor for
resectable stage II–III Gastric Cancer. Dis Markers.
2019:90608452019. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Li Y, Yang JN, Cheng SS and Wang Y:
Prognostic significance of FA score based on plasma fibrinogen and
serum albumin in patients with epithelial ovarian cancer. Cancer
Manag Res. 11:7697–7705. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhang Y and Xiao G: Prognostic
significance of the ratio of fibrinogen and albumin in human
malignancies: A meta-analysis. Cancer Manag Res. 11:3381–3393.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Sun SY, Chen PP, Meng LX, Li L, Mo ZX, Sun
CH, Wang Y and Liang FH: High preoperative plasma fibrinogen and
serum albumin score is associated with poor survival in operable
esophageal squamous cell carcinoma. Dis Esophagus. 322019.doi:
10.1093/dote/doy057.
|
|
30
|
Zhang J, Li SQ, Liao ZH, Jiang YH, Chen
QG, Huang B, Liu J, Xu YM, Lin J, Ying HQ and Wang XZ: Prognostic
value of a novel FPR biomarker in patients with surgical stage II
and III gastric cancer. Oncotarget. 8:75195–75205. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Batschauer AP, Figueiredo CP, Bueno EC,
Ribeiro MA, Dusse LM, Fernandes AP, Gomes KB and Carvalho MG:
D-dimer as a possible prognostic marker of operable hormone
receptor-negative breast cancer. Ann Oncol. 21:1267–1272. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Tsimafeyeu IV, Demidov LV, Madzhuga AV,
Somonova OV and Yelizarova AL: Hypercoagulability as a prognostic
factor for survival in patients with metastatic renal cell
carcinoma. J Exp Clin Cancer Res. 28:302009. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Dolan RD, Laird BJA, Horgan PG and
McMillan DC: The prognostic value of the systemic inflammatory
response in randomised clinical trials in cancer: A systematic
review. Crit Rev Oncol Hematol. 132:130–137. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Bilen MA, Martini DJ, Liu Y, Lewis C,
Collins HH, Shabto JM, Akce M, Kissick HT, Carthon BC, Shaib WL, et
al: The prognostic and predictive impact of inflammatory biomarkers
in patients who have advanced-stage cancer treated with
immunotherapy. Cancer. 125:127–134. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Schütte K, Tippelt B, Schulz C, Röhl FW,
Feneberg A, Seidensticker R, Arend J and Malfertheiner P:
Malnutrition is a prognostic factor in patients with hepatocellular
carcinoma (HCC). Clin Nutr. 34:1122–1127. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Maasberg S, Knappe-Drzikova B, Vonderbeck
D, Jann H, Weylandt KH, Grieser C, Pascher A, Schefold JC, Pavel M,
Wiedenmann B, et al: Malnutrition predicts clinical outcome in
patients with neuroendocrine neoplasia. Neuroendocrinology.
104:11–25. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Palumbo JS, Talmage KE, Massari JV, La
Jeunesse CM, Flick MJ, Kombrinck KW, Jirousková M and Degen JL:
Platelets and fibrin(ogen) increase metastatic potential by
impeding natural killer cell-mediated elimination of tumor cells.
Blood. 105:178–185. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Ridker PM, MacFadyen JG, Thuren T, Everett
BM, Libby P and Glynn RJ: Effect of interleukin-1β inhibition with
canakinumab on incident lung cancer in patients with
atherosclerosis: Exploratory results from a randomised,
double-blind, placebo-controlled trial. Lancet. 390:1833–1842.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Mantovani A: Cancer: Inflaming metastasis.
Nature. 457:36–37. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
40
|
Greten FR and Grivennikov SI: Inflammation
and cancer: Triggers, mechanisms, and consequences. Immunity.
51:27–41. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Kim S, Takahashi H, Lin WW, Descargues P,
Grivennikov S, Kim Y, Luo JL and Karin M: Carcinoma-produced
factors activate myeloid cells through TLR2 to stimulate
metastasis. Nature. 457:102–106. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Marin Caro MM, Laviano A and Pichard C:
Nutritional intervention and quality of life in adult oncology
patients. Clin Nutr. 26:289–301. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Savino W and Dardenne M: Nutritional
imbalances and infections affect the thymus: Consequences on
T-cell-mediated immune responses. Proc Nutr Soc. 69:636–643. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Spek CA, Versteeg HH and Borensztajn KS:
Anticoagulant therapy of cancer patients: Will patient selection
increase overall survival? Thromb Haemost. 114:530–536. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Wu CY, Wu MS, Kuo KN, Wang CB, Chen YJ and
Lin JT: Effective reduction of gastric cancer risk with regular use
of nonsteroidal anti-inflammatory drugs in Helicobacter
pylori-infected patients. J Clin Oncol. 28:2952–2957. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Klek S, Scislo L, Walewska E, Choruz R and
Galas A: Enriched enteral nutrition may improve short-term survival
in stage IV gastric cancer patients: A randomized, controlled
trial. Nutrition. 36:46–53. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Lin Y, Liu Z, Qiu Y, Zhang J, Wu H, Liang
R, Chen G, Qin G, Li Y and Zou D: Clinical significance of plasma
D-dimer and fibrinogen in digestive cancer: A systematic review and
meta-analysis. Eur J Surg Oncol. 44:1494–1503. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Davalos D and Akassoglou K: Fibrinogen as
a key regulator of inflammation in disease. Semin Immunopathol.
34:43–62. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Ferrigno D, Buccheri G and Ricca I:
Prognostic significance of blood coagulation tests in lung cancer.
Eur Respir J. 17:667–673. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Palumbo JS, Kombrinck KW, Drew AF, Grimes
TS, Kiser JH, Degen JL and Bugge TH: Fibrinogen is an important
determinant of the metastatic potential of circulating tumor cells.
Blood. 96:3302–3309. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Im JH, Fu W, Wang H, Bhatia SK, Hammer DA,
Kowalska MA and Muschel RJ: Coagulation facilitates tumor cell
spreading in the pulmonary vasculature during early metastatic
colony formation. Cancer Res. 64:8613–8619. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Yu X, Hu F, Yao Q, Li C, Zhang H and Xue
Y: Serum fibrinogen levels are positively correlated with advanced
tumor stage and poor survival in patients with gastric cancer
undergoing gastrectomy: A large cohort retrospective study. BMC
Cancer. 16:4802016. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Perisanidis C, Psyrri A, Cohen EE,
Engelmann J, Heinze G, Perisanidis B, Stift A, Filipits M, Kornek G
and Nkenke E: Prognostic role of pretreatment plasma fibrinogen in
patients with solid tumors: A systematic review and meta-analysis.
Cancer Treat Rev. 41:960–970. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Pfensig C, Dominik A, Borufka L, Hinz M,
Stange J and Eggert M: A new application for albumin dialysis in
extracorporeal organ support: Characterization of a putative
interaction between human albumin and proinflammatory cytokines
IL-6 and TNFα. Artif Organs. 40:397–402. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Diakos CI, Charles KA, McMillan DC and
Clarke SJ: Cancer-related inflammation and treatment effectiveness.
Lancet Oncol. 15:e493–e503. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Paccagnella A, Morassutti I and Rosti G:
Nutritional intervention for improving treatment tolerance in
cancer patients. Curr Opin Oncol. 23:322–330. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Gupta D and Lis CG: Pretreatment serum
albumin as a predictor of cancer survival: A systematic review of
the epidemiological literature. Nutr J. 9:692010. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Ouyang X, Dang Y, Zhang F and Huang Q: Low
serum albumin correlates with poor survival in gastric cancer
patients. Clin Lab. 64:239–245. 2018. View Article : Google Scholar : PubMed/NCBI
|
